| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/01/2009 | US20090004271 Morselized foam for wound treatment |
| 01/01/2009 | US20090004261 Pharmaceutical composition for oral administration of a pyrazole-3-carboxamide derivative |
| 01/01/2009 | US20090004253 Composite device for the repair or regeneration of tissue |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004219 Novel Strain of Schizochytrium limacinum useful in the production of lipids and Extracellular Polysaccharides and process thereof |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004196 Method of inhibiting osteoclast activity |
| 01/01/2009 | US20090004191 Expansion of Stem/Progenitor Cells by Inhibition of Enzymatic Reactions Catalyzed by the Sir2 Family of Enzymes |
| 01/01/2009 | US20090004186 Effector function enhanced recombinant antibody composition |
| 01/01/2009 | US20090004122 Skin and surface disinfectant compositions containing botanicals |
| 01/01/2009 | US20090004116 In vivo optical imaging |
| 01/01/2009 | US20090004110 Multi-functional gelatin particle and its use |
| 12/31/2008 | WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/31/2008 | WO2009002209A1 Substance for dermatological medicinal agents based on microbiotic collagenase 'ultra-lisin' |
| 12/31/2008 | WO2009002166A1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 12/31/2008 | WO2009002148A1 Food composition for prodromal dementia patients |
| 12/31/2008 | WO2009002146A1 Supporting activities of daily living |
| 12/31/2008 | WO2009001928A1 Peptide having hypotensive activity |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001743A1 Novel adamts-13 mutant |
| 12/31/2008 | WO2009001730A1 Novel compound having β secretase inhibitory activity |
| 12/31/2008 | WO2009001661A1 Medicinal agent for prevention or treatment of alzheimer's disease |
| 12/31/2008 | WO2009001555A1 Expression controller of type i interferon |
| 12/31/2008 | WO2009001551A1 Regulator of activity of bone-forming protein |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2009000145A1 Use and preparation of paeoniflorin and the composition thereof |
| 12/31/2008 | WO2008081463A3 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 12/31/2008 | WO2008003978A3 Dioxo-alkanes and dioxo-alkenes |
| 12/31/2008 | WO2007092735A3 An extracorporeal cell-based therapeutic device and delivery system |
| 12/31/2008 | EP2009101A1 Antibody modification method for purifying bispecific antibody |
| 12/31/2008 | EP2009025A1 Method of inhibiting osteoclast activity |
| 12/31/2008 | EP2009011A1 Nitrogen-containing heterocyclic compound |
| 12/31/2008 | EP2008657A2 Use of rapamycin derivatives in vasculopathies |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP2008649A1 Spill resistant pharmaceutical compositions |
| 12/31/2008 | EP2007424A2 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites |
| 12/31/2008 | EP1855665B1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease |
| 12/31/2008 | EP1561820B1 Anthelmintic substance fki-1033 and process for producing the same |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | EP1513922B1 Pasteurisation process for microbial cells and microbial oil |
| 12/31/2008 | EP1507775B1 Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 12/31/2008 | EP1494685B1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker |
| 12/31/2008 | EP1465610B1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 12/31/2008 | EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 12/31/2008 | EP1413332B1 Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction |
| 12/31/2008 | EP1406867B1 Thiolalkyl benzoic acid derivatives |
| 12/31/2008 | EP1402788B1 Body temperature-raising agent of amino acids for eating or drinking and for medical use |
| 12/31/2008 | EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 12/31/2008 | EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 12/31/2008 | EP1212339B1 2'-o-acetamido modified monomers and oligomers |
| 12/31/2008 | EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis |
| 12/31/2008 | EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 12/31/2008 | CN101336230A Pharmaceutical for use in the treatment of ureterolithiasis |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333215A Method for synthesizing sunitinib alkali |
| 12/31/2008 | CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 12/31/2008 | CN101333187A Novel PI3K enzyme inhibitors and uses thereof |
| 12/31/2008 | CN101333156A Antrodia camphorate pimelie kelone compounds for releasing physiological fatigue |
| 12/31/2008 | CN101332275A Baby pig fattening decoction |
| 12/31/2008 | CN101331912A Mixed type biology feed additive and preparation method thereof |
| 12/31/2008 | CN101331906A Drink containing Congrong and coffee |
| 12/31/2008 | CN100447244C BAFF receptor (BCMA), immunoregulatory agent |
| 12/31/2008 | CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100447141C Hetero-bicyclic crf antagonists |
| 12/31/2008 | CN100446820C Multiple compartment bag assembly for dialysis fluid |
| 12/31/2008 | CN100446809C Injectable depot composition |
| 12/31/2008 | CN100446808C Medicine for treating cold after delivery |
| 12/31/2008 | CN100446776C Superoxide anion decomposing agent |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/31/2008 | CA2692309A1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 12/31/2008 | CA2691937A1 Substrate reduction therapy |
| 12/31/2008 | CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | CA2690371A1 Peptide having hypotensive activity |
| 12/30/2008 | US7470714 GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 12/30/2008 | US7470704 Benzonaphthyridines |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470527 Preparation of microbial oil |
| 12/30/2008 | US7470506 Fitness assay and associated methods |
| 12/30/2008 | US7470438 Inhibiting expression of metalloproteases, collagen degradation, and/or UV-induced skin degradation; collagenase inhibitors; wrinkle resistance |
| 12/30/2008 | US7470436 Water-soluble composition containing coenzyme Q10 |
| 12/30/2008 | US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is |
| 12/30/2008 | CA2446903C Imidazo ¬1,5-a| pyrimido ¬5,4-d| benzazepine derivatives as gaba a receptor modulators |
| 12/30/2008 | CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i |
| 12/30/2008 | CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2391497C Use of 5ht3 agonists for relaxing the fundus |
| 12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
| 12/30/2008 | CA2387873C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/30/2008 | CA2285389C Use of cytoskeletal inhibitors for the prevention of restenosis |
| 12/30/2008 | CA2250295C Water soluble paclitaxel prodrugs |